ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.05 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

ZyVersa Therapeutics (ZVSA) Asset Utilization Ratio (2023 - 2026)

Updated

Analysis

ZyVersa Therapeutics (ZVSA) Asset Utilization Ratio (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,171.71 Bn 1,140.30 Bn 19.71 Bn 0.62
2 Johnson & Johnson 642.13 Bn 560.65 Bn 17.26 Bn 0.49
3 AbbVie 501.64 Bn 474.75 Bn 12.70 Bn 0.47
4 Merck 375.66 Bn 330.04 Bn 12.21 Bn 0.52
5 Novartis Ag 302.79 Bn 266.78 Bn 11.24 Bn 0.46
6 Astrazeneca 268.68 Bn 242.37 Bn 12.86 Bn 0.51
7 Amgen 242.43 Bn 197.83 Bn 7.24 Bn 0.40
8 Gilead Sciences 193.69 Bn 167.89 Bn 6.22 Bn 0.58
9 Pfizer 172.47 Bn 119.12 Bn 10.94 Bn 0.31
10 ZyVersa Therapeutics 404,796.06 -599,719.94 - -0.87
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.87
Dec 31, 2025 -0.68
Sep 30, 2025 -0.05
Jun 30, 2025 -0.03
Mar 31, 2025 -0.02
Dec 31, 2024 -0.01
Sep 30, 2024 -0.01
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
API Access

ZyVersa Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ZVSA&period=max&api_key=YOUR_API_KEY